New hope for kids with bowel disease: 8-Week treatment trial

NCT ID NCT04314375

Recruiting now Disease control Sponsor: Bausch Health Americas, Inc. Source: ClinicalTrials.gov ↗

Summary

This study is testing whether budesonide extended-release tablets can help children aged 5-17 with mild to moderate ulcerative colitis achieve remission. Participants will take either the medication or a placebo for 8 weeks while continuing their standard background treatments. The main goal is to see if more children taking the medication achieve clinical remission compared to those taking the placebo.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Bausch Health Site 003
RECRUITING

Indianapolis, Indiana, 46202, United States
Bausch Health Site 006
RECRUITING

The Bronx, New York, 10467, United States
Bausch Health Site 008
RECRUITING

Garden Grove, California, 92845, United States
Bausch Health Site 010
RECRUITING

Greenville, North Carolina, 27834, United States

Conditions

Explore the condition pages connected to this study.

ULCERATIVE COLITIS